CTC Alternative Strategies’s Sherwin-Williams SHW Stock Holding History

CTC Alternative Strategies’s Portfolio SHW Stock Details SHW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-740	Closed	-$282K	–	82
2024 Q3	$282K	Buy	+740	New	+$258K	0.35%	38
2023 Q4	–	Sell	-2,500	Closed	-$638K	–	123
2023 Q3	$638K	Buy	+2,500	New	+$669K	1.2%	30

Other funds holding SHW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

CTC Alternative Strategies's SHW Position: Q4 2024 in Review

CTC Alternative Strategies sold out of Sherwin-Williams (SHW) in Q4 2024, closing a stake of 740 shares — an estimated $282K sold.

CTC Alternative Strategies first reported a position in SHW in Q3 2023 and held it in 2 quarters. The position peaked at $638K in Q3 2023. 1,678 funds tracked by Wall St. Rank hold SHW as of Q4 2024.

CTC Alternative Strategies reported no remaining Sherwin-Williams position as of Q4 2024 after selling out during the quarter.
CTC Alternative Strategies sold 740 Sherwin-Williams shares in Q4 2024, an estimated $282K.
CTC Alternative Strategies first reported a position in Sherwin-Williams in Q3 2023 and held it in 2 quarters.
CTC Alternative Strategies's Sherwin-Williams position peaked at $638K in Q3 2023.
1,678 funds tracked by Wall St. Rank held Sherwin-Williams as of Q4 2024.

Based on CTC Alternative Strategies's 13F filing for Q4 2024, filed 19 Feb 2025.